JPL Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$690K Sell
751
-30
-4% -$30.4K 0.16% 83
2025
Q4
$839K Sell
781
-16
-2% -$15.3K 0.2% 84
2025
Q3
$608K Sell
797
-41
-5% -$30.5K 0.14% 90
2025
Q2
$653K Sell
838
-80
-9% -$62.2K 0.18% 86
2025
Q1
$758K Buy
918
+19
+2% +$15.8K 0.22% 80
2024
Q4
$694K Buy
+899
New +$744K 0.2% 80
2024
Q2
$709K Buy
783
+216
+38% +$173K 0.35% 71
2024
Q1
$441K Buy
567
+12
+2% +$8.54K 0.24% 81
2023
Q4
$324K Buy
+555
New +$324K 0.23% 86

Other funds holding LLY

JPL Wealth Management's LLY Position: Q1 2026 in Review

JPL Wealth Management reduced its Eli Lilly (LLY) stake by 3.8% in Q1 2026, selling an estimated $30.4K and leaving 751 shares worth $690K. The position accounts for 0.16% of the portfolio, ranked #83.

JPL Wealth Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $839K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • JPL Wealth Management held 751 shares of Eli Lilly worth $690K as of Q1 2026.
  • JPL Wealth Management sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
  • Eli Lilly made up 0.16% of JPL Wealth Management's portfolio in Q1 2026, its #83 holding.
  • JPL Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • JPL Wealth Management's Eli Lilly position peaked at $839K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.